Scienture Holdings, Inc. (SCNX) - Latest Market Data

Price & Market Data

Price: $0.408

Daily Change: +$0.008 / 1.96%

Daily Range: $0.39 - $0.419

Market Cap: $16,333,588

Daily Volume: 296,155

Performance Metrics

1 Week: 0.22%

1 Month: 1.13%

3 Months: 1.23%

6 Months: -25.92%

1 Year: -51.82%

YTD: -18.44%

About Scienture Holdings, Inc. (SCNX)

Quick facts and data for Scienture Holdings, Inc. (SCNX). Price: 0.408, daily change: +$0.008 / 1.96%. Market cap: 16,333,588. Performance across all periods.

Company Details

Employees: 9

Sector: Commercial services

Industry: Miscellaneous commercial services

Country: United States

Details

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Selected stocks

enCore Energy Corp. (EU)

Shengfeng Development Limited (SFWL)

Credit Suisse Asset Management Income Fund, Inc. (CIK)

JE Cleantech Holdings Limited (JCSE)

FTAI Infrastructure Inc. (FIP)